Medical Properties (MPT) Fundamental Analysis: Revenue, Earnings & Valuation

7.81 / 10

Outperform

Fundamentals are rated Outperform with a 7.8/10 score. Strengths include Revenue‑MV, cash increase, and net‑asset growth; however Profit‑MV and Net‑income‑Revenue lag. Key factor scores: Revenue‑MV = 3, Cash‑UP = 2, Net‑assets = 2, Income‑tax = 2, PB‑ROE = 1.

Analysis Checks(4/10)

Revenue-MV

Value-0.29

Score3/3

Weight43.99%

1M Return4.88%

Net assets per share (growth rate compared to beginning of year %)

Value-4.15

Score2/3

Weight-0.88%

1M Return-0.13%

Total operating revenue (YoY growth rate %)

Value-2.36

Score0/3

Weight-12.14%

1M Return-1.96%

Profit-MV

Value0.66

Score0/3

Weight2.16%

1M Return0.26%

Net income-Revenue

Value-0.74

Score0/3

Weight5.22%

1M Return0.70%

PB-ROE

Value-0.86

Score1/3

Weight8.37%

1M Return0.99%

Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)

Value-4.69

Score0/3

Weight-8.04%

1M Return-1.32%

Income tax / Total profit (%)

Value-16.27

Score2/3

Weight7.86%

1M Return1.06%

Cash-UP

Value1.81

Score2/3

Weight73.22%

1M Return6.01%

Asset-MV

Value0.04

Score0/3

Weight-19.76%

1M Return-2.43%

Is MPT undervalued or overvalued?

MPT scores 7.81/10 on fundamentals and holds a Discounted valuation at present. Backed by its -5.87% ROE, -28.39% net margin, -9.99 P/E ratio, 0.60 P/B ratio, and 88.56% earnings growth, these metrics solidify its Outperform investment rating.